Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCT365623 is an orally bioavailable Lysyl Oxidase inhibitor with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 329.00 | |
5 mg | In stock | $ 798.00 | |
10 mg | In stock | $ 1,090.00 | |
25 mg | In stock | $ 1,650.00 | |
50 mg | In stock | $ 2,230.00 | |
100 mg | In stock | $ 2,930.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 995.00 |
Description | CCT365623 is an orally bioavailable Lysyl Oxidase inhibitor with good anti-LOX potency, selectivity, pharmacokinetic properties, as well as anti-metastatic efficacy. |
Synonyms | CCT-365623, CCT 365623 |
Molecular Weight | 407.53 |
Formula | C18H17NO4S3 |
CAS No. | 2126134-01-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.08 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCT365623 2126134-01-6 Neuroscience Monoamine Oxidase CCT-365623 CCT 365623 inhibitor inhibit